Navigation Links
Moose drool inhibits growth of toxic fungus: York U research
Date:7/24/2014

TORONTO, June 24, 2014 Some sticky research out of York University shows a surprisingly effective way to fight against a certain species of toxic grass fungus: moose saliva (yes moose saliva).

Published in this month's Biology Letters, "Ungulate saliva inhibits a grassendophyte mutualism" shows that moose and reindeer saliva, when applied to red fescue grass (which hosts a fungus called epichlo festucae that produces the toxin ergovaline) results in slower fungus growth and less toxicity.

"Plants have evolved defense mechanisms to protect themselves, such as thorns, bitter-tasting berries, and in the case of certain types of grass, by harbouring toxic fungus deep within them that can be dangerous or even fatal for grazing animals," says York U Biology Professor Dawn Bazely, who worked with University of Cambridge researcher Andrew Tanentzap and York U researcher Mark Vicari on the project. "We wanted to find out how moose were able to eat such large quantities of this grass without negative effects."

Inspired by an earlier study that showed that moose grazing and saliva distribution can have a positive effect on plant growth, the research team set out to test an interesting hypothesis whether moose saliva may, in fact, "detoxify" the grass before it is eaten.

Working in partnership with the Toronto Zoo, the team collected saliva samples from moose and reindeer, which they then smeared onto clipped samples of red fescue grass carrying the toxic fungus, simulating the effect of grazing. They found that the application of saliva produced rapid results, inhibiting fungus growth within 12-36 hours.

"We found that the saliva worked very quickly in slowing the growth of the fungus, and the fungus colonies," says Bazely. "In addition, by applying multiple applications of saliva to the grass over the course of two months, we found we could lower the concentration of ergovaline between 41 and 70 per cent."

Bazely says that because moose tend to graze within a defined home range, it's possible that certain groups of plants are receiving repeated exposure to the moose saliva, which over time has resulted in fewer toxins within their preferred area.

"We know that animals can remember if certain plants have made them feel ill, and they may avoid these plants in future," says Bazely. "This study the first evidence, to our knowledge, of herbivore saliva being shown to 'fight back' and slow down the growth of the fungus."

York University is helping to shape the global thinkers and thinking that will define tomorrow. York's unwavering commitment to excellence reflects a rich diversity of perspectives and a strong sense of social responsibility that sets us apart. A York U degree empowers graduates to thrive in the world and achieve their life goals through a rigorous academic foundation balanced by real-world experiential education. As a globally recognized research centre, York is fully engaged in the critical discussions that lead to innovative solutions to the most pressing local and global social challenges. York's 11 faculties and 28 research centres are thinking bigger, broader and more globally, partnering with 288 leading universities worldwide. York's community is strong − 55,000 students, 7,000 faculty and staff, and more than 250,000 alumni.


'/>"/>

Contact: Robin Heron
rheron@yorku.ca
416-736-2100 x22097
York University
Source:Eurekalert  

Related biology news :

1. Coyote more likely to make a meal out of moose than we thought: Study
2. Maple syrup, moose, and the local impacts of climate change
3. Somatosensory stimulation inhibits excitability of pyramidal cells in rat hippocampal CA1
4. Acidic tumor pH inhibits drug effect
5. Gabapentin inhibits central sensitization during migraine
6. How the Parkin enzyme inhibits neuronal cell death
7. Active component from wine-processed Fructus corni inhibits hippocampal neuron apoptosis
8. Gene transduction inhibits post-epileptic hippocampal synaptic reconstruction
9. New agent inhibits HCV replication in mouse models -- No resistance seen
10. Molecule found that inhibits estrogen, key risk factor for endometrial and breast cancers
11. An increase in temperature by 2050 may be advantageous to the growth of forage plants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Moose drool inhibits growth of toxic fungus: York U research
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... Safety, HealthCare, and Finance sectors announced today that Leaders in Community ... and deploy a community-based supportive services program to reduce recidivism in ... expanding its presence in the state. ... This new program, which is expected to commence ...
(Date:12/16/2016)... , Dec 16, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... The biometric ... grow at a CAGR of 14.06% from 2016 to 2021. The ... is projected to reach 854.8 Million by 2021. The growth of ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... ... January 13, 2017 , ... ... demand that it has found among its diverse customer base. The latest entry ... in most brands electroporators including BTX and Bio-Rad. FireflySci is introducing three distinct ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... of performing routine electrochemical biosensing has increased dramatically. Primarily driven by the ... and quantification of various analytes in complex samples. , Screen-printed ...
(Date:1/12/2017)... 2017   Protein Sciences Corporation , a ... Flublok Influenza Vaccine ®, announced today that its ... safety results and induced strong neutralizing antibodies against ... is expected to advance into human clinical trials ... Institute of Technology in Immunobiologicals of the Oswaldo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial ... of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The ... percent of these heavily pretreated patients saw clinical benefit from the drug, with ...
Breaking Biology Technology: